Cart
sales@molnova.com
Dabigatran ethyl ester
CAS No. 429658-95-7
Dabigatran ethyl ester( Dabigatran ethyl ester | BIBR-951CL | BIBR 951CL | BIBR951CL | UNII-KJ4EH9410G )
Catalog No. M14458 CAS No. 429658-95-7
A reversible and selective, direct thrombin inhibitor (DTI) with Ki value of 4.5 nM.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 45 | In Stock |
|
| 10MG | 82 | In Stock |
|
| 25MG | 149 | In Stock |
|
| 50MG | 262 | In Stock |
|
| 100MG | 411 | In Stock |
|
| 200MG | 577 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameDabigatran ethyl ester
-
NoteResearch use only, not for human use.
-
Brief DescriptionA reversible and selective, direct thrombin inhibitor (DTI) with Ki value of 4.5 nM.
-
DescriptionA reversible and selective, direct thrombin inhibitor (DTI) with Ki value of 4.5 nM; an anticoagulant agent used to prevent stroke with atrial fibrillation.Thrombosis Approved.
-
In Vitro——
-
In Vivo——
-
SynonymsDabigatran ethyl ester | BIBR-951CL | BIBR 951CL | BIBR951CL | UNII-KJ4EH9410G
-
PathwayAutophagy
-
TargetThrombin
-
RecptorThrombin
-
Research AreaCardiovascular Disease
-
IndicationThrombosis
Chemical Information
-
CAS Number429658-95-7
-
Formula Weight499.5643
-
Molecular FormulaC27H29N7O3
-
Purity>98% (HPLC)
-
Solubility10 mM in DMSO
-
SMILESO=C(OCC)CCN(C(C1=CC=C2C(N=C(CNC3=CC=C(C(N)=N)C=C3)N2C)=C1)=O)C4=NC=CC=C4
-
Chemical Nameβ-Alanine, N-[[2-[[[4-(aminoiminomethyl)phenyl]amino]methyl]-1-methyl-1H-benzimidazol-5-yl]carbonyl]-N-2-pyridinyl-, ethyl ester
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Wienen W, et al. Thromb Haemost. 2007 Jul;98(1):155-62.
2. Kansal AR, et al. Heart. 2012 Apr;98(7):573-8.
molnova catalog
related products
-
Dabigatran ethyl est...
Dabigatran ethyl ester hydrochloride is an effective inhibitor of ribosyl dihydronicotinic acid amide dehydrogenase (NQO2) with an IC50 value of 0.8 μM and is a thrombin inhibitor.
-
Enoxaparin sodium
Enoxaparin sodium is a low-molecular-weight heparin (LMWH) that has recently been approved by the US FDA for use in patients with medically managed ST-segment myocardial infarction (STEMI), or STEMI with subsequent percutaneous coronary intervention (PCI).
-
Ximelagatran
Ximelagatran, a direct thrombin inhibitor, can be taken orally and acts solely by inhibiting the actions of thrombin. Ximelagatran is converted to the active agent melagatran in vivo.
